CYTORI THERAPEUTICS INC DEF 14A 8-16-2011

Company

PLUS THERAPEUTICS, INC.

Filed

May 2, 2011

Period of Report

August 16, 2011

Accession Number

0001095981-11-000012

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →